Results 251 to 260 of about 396,895 (313)

Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All

Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic, Daniel Gonzalez, Bernd Meibohm   +2 more
wiley   +1 more source

Interleukin‐18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin‐1 Inhibitors

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the prognostic utility of circulating interleukin‐18 (IL‐18) levels in predicting disease activity, macrophage activation syndrome (MAS), and disease course in patients with Still disease (SD) receiving first‐line IL‐1 inhibitors (IL‐1i).
Matteo Trevisan, Manuela Pardeo, Ivan Caiello, Claudia Bracaglia, Arianna De Matteis, Valentina Matteo, Elena Loricchio, Fabrizio De Benedetti, Giusi Prencipe   +8 more
wiley   +1 more source

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. [PDF]

RMD Open
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S.   +28 more
europepmc   +1 more source

Cellular therapies for rheumatic disease. [PDF]

Curr Opin Rheumatol
Koumpouras F, Caricchio R.
europepmc   +1 more source

Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials. [PDF]

Lupus Sci Med
Connelly K, Morand E, Koelmeyer R, Rajagopala L, Wakhlu A, Hao Y, Liao K, Ayton D, Gorton C, Bennett A, Black N, Cervera R, Costenbader K, Fanouriakis A, Gydesen S, Hjelmeset C, Kamphuis SSM, Karakikla-Mitsakou Z, Navarra S, Ogbu EA, Sciascia S, Wincup C, Yazdany J, Burke L, Mosca M, Pons-Estel GJ.   +25 more
europepmc   +1 more source

Emerging prospective evidence shows that lung ultrasound can reliably detect rheumatoid arthritis-associated ILD: need for standardised protocols and consideration in future guidelines. [PDF]

Eur Respir J
Davidsen JR, Otaola M, Sofíudóttir BK, Wuyts W, Vermant M, Ellingsen T.   +5 more
europepmc   +1 more source

A qualitative study of people with inflammatory arthritis and their partners' perspectives on partner participation in rheumatology consultations. [PDF]

Rheumatol Adv Pract
Hansen CW, Midtgaard J, de Thurah A, Cromhout PF, Esbensen BA.   +4 more
europepmc   +1 more source

Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy. [PDF]

Rheumatology (Oxford)
Freitag M, Kolb P, Falcone V, Claus M, Schröder P, Andreeva I, Rodon L, Ewald M, Deicher FS, Stütz AN, Distler JHW, Blank N, Grieshaber-Bouyer R, Muñoz LE, Lorenz HM, Schett G, Merkt W.   +16 more
europepmc   +1 more source

Contribution of neuromuscular Impairment to physical functional Status in Patients with Lumbar Spinal Stenosis [PDF]

, 1994
Fossel, Anne H., Katz, Jeffrey N., Liang, Matthew H., Lipson, Stephen J., Stucki, Gerold   +4 more
core